(2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide

C214H226N38O10 — CID 158219284

IUPAC(2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide
SMILESCOc1cc(-c2cnn(C)c2)ccc1NC(=O)[C@@H](NCCc1ccc(C)cc1)c1ccccc1.COc1cc(-c2cnn(C)c2)ccc1NC(=O)[C@H](NCCc1ccc(C)cc1)c1ccccc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)c(C)c2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2cnc(-c3cnn(C)c3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)c(C)c2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2cnc(-c3cnn(C)c3)nc2)c2ccccc2)cc1
InChIInChI=1S/2C28H30N4O2.2C28H30N4O.2C26H27N5O.2C25H26N6O/c2*1-20-9-11-21(12-10-20)15-16-29-27(22-7-5-4-6-8-22)28(33)31-25-14-13-23(17-26(25)34-3)24-18-30-32(2)19-24;2*1-20-9-11-22(12-10-20)15-16-29-27(23-7-5-4-6-8-23)28(33)31-25-13-14-26(21(2)17-25)24-18-30-32(3)19-24;2*1-19-8-10-20(11-9-19)14-15-27-25(21-6-4-3-5-7-21)26(32)30-24-13-12-22(16-28-24)23-17-29-31(2)18-23;2*1-18-8-10-19(11-9-18)12-13-26-23(20-6-4-3-5-7-20)25(32)30-22-15-27-24(28-16-22)21-14-29-31(2)17-21/h2*4-14,17-19,27,29H,15-16H2,1-3H3,(H,31,33);2*4-14,17-19,27,29H,15-16H2,1-3H3,(H,31,33);2*3-13,16-18,25,27H,14-15H2,1-2H3,(H,28,30,32);2*3-11,14-17,23,26H,12-13H2,1-2H3,(H,30,32)/t4*27-;2*25-;2*23-/m10101010/s1
InChIKeyGDAUBUBLSOURLI-RDCQQUHSSA-N
MW3490.42 g/mol
LogP36.26
Rot. Bonds66

About (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide

(2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide (PubChem CID 158219284) has the molecular formula C214H226N38O10 and a molecular weight of 3490.42 g/mol. Its IUPAC name is (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide.

Molecular Properties

Compound Name(2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide
PubChem CID158219284
Molecular FormulaC214H226N38O10
Molecular Weight3490.42 g/mol
Exact Mass3487.83
IUPAC Name(2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide
SMILESCOc1cc(-c2cnn(C)c2)ccc1NC(=O)[C@@H](NCCc1ccc(C)cc1)c1ccccc1.COc1cc(-c2cnn(C)c2)ccc1NC(=O)[C@H](NCCc1ccc(C)cc1)c1ccccc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)c(C)c2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2cnc(-c3cnn(C)c3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)c(C)c2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2cnc(-c3cnn(C)c3)nc2)c2ccccc2)cc1
InChIInChI=1S/2C28H30N4O2.2C28H30N4O.2C26H27N5O.2C25H26N6O/c2*1-20-9-11-21(12-10-20)15-16-29-27(22-7-5-4-6-8-22)28(33)31-25-14-13-23(17-26(25)34-3)24-18-30-32(2)19-24;2*1-20-9-11-22(12-10-20)15-16-29-27(23-7-5-4-6-8-23)28(33)31-25-13-14-26(21(2)17-25)24-18-30-32(3)19-24;2*1-19-8-10-20(11-9-19)14-15-27-25(21-6-4-3-5-7-21)26(32)30-24-13-12-22(16-28-24)23-17-29-31(2)18-23;2*1-18-8-10-19(11-9-18)12-13-26-23(20-6-4-3-5-7-20)25(32)30-22-15-27-24(28-16-22)21-14-29-31(2)17-21/h2*4-14,17-19,27,29H,15-16H2,1-3H3,(H,31,33);2*4-14,17-19,27,29H,15-16H2,1-3H3,(H,31,33);2*3-13,16-18,25,27H,14-15H2,1-2H3,(H,28,30,32);2*3-11,14-17,23,26H,12-13H2,1-2H3,(H,30,32)/t4*27-;2*25-;2*23-/m10101010/s1
InChIKeyGDAUBUBLSOURLI-RDCQQUHSSA-N
XLogP36.26
TPSA567.40 Ų
H-Bond Donors16
H-Bond Acceptors40
Rotatable Bonds66
Heavy Atoms262
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003490.42
LogP ≤ 536.26
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1040

Analyze (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide?
The IUPAC name of (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide (CID 158219284) is (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide.
What is the SMILES notation for (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide?
The canonical SMILES for (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide is COc1cc(-c2cnn(C)c2)ccc1NC(=O)[C@@H](NCCc1ccc(C)cc1)c1ccccc1.COc1cc(-c2cnn(C)c2)ccc1NC(=O)[C@H](NCCc1ccc(C)cc1)c1ccccc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)c(C)c2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2cnc(-c3cnn(C)c3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)c(C)c2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2cnc(-c3cnn(C)c3)nc2)c2ccccc2)cc1.
What is the InChIKey of (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide?
The InChIKey is GDAUBUBLSOURLI-RDCQQUHSSA-N. The full InChI is InChI=1S/2C28H30N4O2.2C28H30N4O.2C26H27N5O.2C25H26N6O/c2*1-20-9-11-21(12-10-20)15-16-29-27(22-7-5-4-6-8-22)28(33)31-25-14-13-23(17-26(25)34-3)24-18-30-32(2)19-24;2*1-20-9-11-22(12-10-20)15-16-29-27(23-7-5-4-6-8-23)28(33)31-25-13-14-26(21(2)17-25)24-18-30-32(3)19-24;2*1-19-8-10-20(11-9-19)14-15-27-25(21-6-4-3-5-7-21)26(32)30-24-13-12-22(16-28-24)23-17-29-31(2)18-23;2*1-18-8-10-19(11-9-18)12-13-26-23(20-6-4-3-5-7-20)25(32)30-22-15-27-24(28-16-22)21-14-29-31(2)17-21/h2*4-14,17-19,27,29H,15-16H2,1-3H3,(H,31,33);2*4-14,17-19,27,29H,15-16H2,1-3H3,(H,31,33);2*3-13,16-18,25,27H,14-15H2,1-2H3,(H,28,30,32);2*3-11,14-17,23,26H,12-13H2,1-2H3,(H,30,32)/t4*27-;2*25-;2*23-/m10101010/s1.
What are the key properties of (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide?
(2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide has a molecular weight of 3490.42 g/mol, XLogP of 36.26, 66 rotatable bonds, 16 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide is sourced from PubChem (CID 158219284), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).